Xencor's IPO

Xencor raised a round of funding on December 03, 2013. Investors include Public.

Xencor engineers biotherapeutics using its Protein Design Automation technology platform, and is a provider in the field of antibody engineering to significantly improve antibody half-life, immune-reg…

Articles about Xencor's IPO: